Thus, the knockdown expression of PDIA2 and its associated metabolic reprogramming inhibit cancer cell growth and defer fast cancer development, particularly in the early stage, highlighting a prompting role of PDIA2 in inflammation to cancerous transformation. This evidence concerns the gene PDIA2 and cancer.